Achieved over $50 million of cash receipts, including $33.6 million in royalties and $16.9 million milestones, in full year ...
Zymeworks to receive $250 million under a royalty-backed note financing from Royalty Pharma with repayments due from 30% of worldwide tiered royalties on Ziihera until fully repaid Zymeworks to retain ...
Royalty Pharma delivered robust FY25 results, with double-digit growth in Royalty Receipts and Portfolio Receipts, and disciplined capital deployment. RPRX expanded its portfolio through $2.6B in new ...
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. PrairieSky Royalty reported record oil royalty production ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results